Publicacións nas que colabora con ANTONIA ARANEGA JIMÉNEZ (91)

2016

  1. Meroxest improves the prognosis of immunocompetent C57BL/6 mice with allografts of E0771 mouse breast tumor cells

    Archives of Medical Science, Vol. 12, Núm. 5, pp. 919-927

2015

  1. Poly(butylcyanoacrylate) and Poly(ε-caprolactone) Nanoparticles Loaded with 5-Fluorouracil Increase the Cytotoxic Effect of the Drug in Experimental Colon Cancer

    AAPS Journal, Vol. 17, Núm. 4, pp. 918-929

2014

  1. Application of nanotechnology in the treatment and diagnosis of gastrointestinal cancers: Review of recent patents

    Recent Patents on Anti-Cancer Drug Discovery, Vol. 9, Núm. 1, pp. 21-34

  2. Cancer stem cells and their implication in breast cancer

    European Journal of Clinical Investigation, Vol. 44, Núm. 7, pp. 678-687

  3. Erratum: A novel double-enhanced suicide gene therapy in a colon cancer cell line mediated by gef and apoptin (BioDrugs DOI : 10.1007/s40259-013-0055-0)

    BioDrugs

  4. Novel merosesquiterpene exerts a potent antitumor activity against breast cancer cells in vitro and in vivo

    European Journal of Medicinal Chemistry, Vol. 79, pp. 1-12

  5. Transcriptional Profiling of Peripheral Blood in Pancreatic Adenocarcinoma Patients Identifies Diagnostic Biomarkers

    Digestive Diseases and Sciences, Vol. 59, Núm. 11, pp. 2714-2720

2013

  1. Antitumor properties of natural compounds and related molecules

    Recent Patents on Anti-Cancer Drug Discovery, Vol. 8, Núm. 3, pp. 203-215

  2. Colon cancer therapy: Recent developments in nanomedicine to improve the efficacy of conventional chemotherapeutic drugs

    Anti-Cancer Agents in Medicinal Chemistry, Vol. 13, Núm. 8, pp. 1204-1216

  3. Four accessory (supernumerary) intrathoracic ribs: A case report

    Surgical and Radiologic Anatomy, Vol. 35, Núm. 7, pp. 627-629

  4. Modulation of multidrug resistance gene expression in peripheral blood mononuclear cells of lung cancer patients and evaluation of their clinical significance

    Cancer Chemotherapy and Pharmacology, Vol. 71, Núm. 2, pp. 537-541

  5. RNA interference in the treatment of colon cancer

    BioDrugs, Vol. 27, Núm. 4, pp. 317-327

  6. Regulatory systems in bone marrow for hematopoietic stem/progenitor cells mobilization and homing

    BioMed Research International, Vol. 2013

2012

  1. 5-Fluorouracil derivatives: A patent review

    Expert Opinion on Therapeutic Patents, Vol. 22, Núm. 2, pp. 107-123

  2. 5-fluorouracil-loaded poly(ε-caprolactone) nanoparticles combined with phage E gene therapy as a new strategy against colon cancer

    International Journal of Nanomedicine, Vol. 7, pp. 95-107

  3. DNA methylation plasticity of human adipose-derived stem cells in lineage commitment

    American Journal of Pathology, Vol. 181, Núm. 6, pp. 2079-2093

  4. Doxorubicin-loaded nanoparticles: New advances in breast cancer therapy

    Anti-Cancer Agents in Medicinal Chemistry, Vol. 12, Núm. 9, pp. 1058-1070

  5. Gef gene therapy enhances the therapeutic efficacy of cytotoxics in colon cancer cells

    Biomedicine and Pharmacotherapy, Vol. 66, Núm. 7, pp. 563-567

  6. How is gene transfection able to improve current chemotherapy? The role of combined therapy in cancer treatment

    Current Medicinal Chemistry, Vol. 19, Núm. 12, pp. 1870-1888

  7. MGMT promoter methylation status and MGMT and CD133 immunohistochemical expression as prognostic markers in glioblastoma patients treated with temozolomide plus radiotherapy

    Journal of Translational Medicine, Vol. 10, Núm. 1